|
|
|
|
 |
November & December 2002
Women and Coronary Heart Disease
A Practical Approach Based on Guidelines
By Louise A. Laramée, MD, FRCPC
The diagnosis of coronary disease in women presents a particular challenge. This article provides practical tools to help in the assessment and diagnosis of women presenting with symptoms compatible with angina.
What’s New in Heart Failure?
By Richard Townley, MD, FRCPC ; and Jonathan Howlett, MD, FRCPC, FACC
A large part of the population is at risk for congestive heart failure. With one-year mortality rates approaching 40%, it is crucial to understand the newest and best treatment applications, so this number is controlled.
Cardiovascular Reporter: Statin Therapy Follows Angioplasty?
By Gregory Curnew, MD, CM, FRCPC
Results from the Lescol Intervention Prevention Study (LIPS), presented at the American College of Cardiology 51st Annual Scientific Session Late-Breaking Clinical Trials in Atlanta, Georgia last March, provide insight into why patients undergoing angioplasty would benefit from being on statin therapy following angioplasty.
CardioCase of the month
Heeding the Signs
A 52-year-old building superintendent presented to the emergency department at four in the morning with a three-day history of progressive exertional dyspnea.
By Robert Myers, MD, ABIM, FACC
ECG of the Month
Non-Sense or Nonsense? By Paul Stobie, MBBS, FRACP and Martin S. Green, MD, FRCPC
Heart Smart Nutrition
The Buzz on Caffeine and Heart Problems
By Maureen Elhatton, RD
Recipe of the Month
No-Fuss Pot Roast with Onions
By Anne Lindsay
Patient Information
Heart-Smart Tips on Caffeine
By Maureen Elhatton, RD
|
 |
October 2002
Preventing Progression: Evidence-based treatment for Diabetic Nephropathy
By Ellen D. Burgess, MD, FACP, FRCPC
All patients with diabetic nephropathy and one-third of patients with Type 2 diabetes will have hypertension. This article will discuss the factors leading to this condition and multi-factoral considerations for treatment.
Cardiovascular Reporter: Early Direct Angioplasty is Superior
By Gregory Curnew, MD, CM, FRCPC
Clinical Issues in Hypertension
Physical Activity Prescriptions
In response to public interest in preventing and treating cardiovascular disease, the World Health Organization has promoted lifestyle modification as an effective method for reducing high blood pressure (BP) and overall cardiovascular risk.
By By Robert J. Petrella, MD, PhD in Association with the Canadian Coalition for High Blood Pressure Prevention and Control
CardioCase of the month
Target BP and the Right Concoction
A 54-year-old non-smoking male was diagnosed with hypertension 10 years ago, and with diabetes five years ago. He has been taking hydrochlorothiazide for his hypertension, and metformin for his diabetes.
By Ellen D. Burgess, MD, FACP, FRCPC
ECG of the Month
An Unusual Case
By Martin S. Green, MD, FRCPC
Heart Smart Nutrition
Antioxidant Vitamin Supplementation and Coronary Artery Disease
By Maureen Elhatton, RD
Recipe of the Month
Swiss Muesli with Bananas
By Anne Lindsay
Patient Information
Antioxidants for Heart Health
By Maureen Elhatton, RD
|
|
|
 |
September 2002
Combination Therapy in Hypertensive Patients
The likelihood of lowering blood pressure to target could increase by using combination drug therapy to treat patients with hypertension.
By Ellen D. Burgess MD, FACP FRCPC
NEW!
Cardio
Case of the month
Fever and a New Heart Murmur
A 43-year-old male stockbroker presented with fever and general malaise.
By Subodh Verma, MD, PhD; Mitesh Badiwala, BSc; and Nicole Look Hong, BSc
Cardiovascular Reporter
Update on Folic Acid Supplementation
By Gregory P. Curnew, MD, CM, FRCPC
ECG of the Month
Ups and Downs
By Martin S. Green, MD, FRCPC
Heart Smart Nutrition
Vitamin K Interactions with Warfarin Anticoagulation Therapy
By Maureen Elhatton, RD
Recipe of the Month
Lemon Sugar Cookies
By Anne Lindsay
Patient Information
Warfarin Anticoagulation Therapy
By Maureen Elhatton, RD
Clinical Issues in Hypertension
Secondary Hypertension: Diagnosis and Management Options
Secondary hypertension is defined as being present when there is an identifiable cause contributing to high blood pressure (BP), as opposed to the primary form, also known as “essential hypertension.”
By Karthikeyan Ananthasubramaniam, MD, FACC; Vanji Karthikeyan, MD; and Terrence D. Ruddy, MD, FRCPC
|
|
|
 |
|
|
|
 |
June & July 2002
Antihypertensives: A Drug Review
Dr. Caren Wu Tara Cowtan Norman Campbell
The review summarizes risk stratification in order to initiate treatment, reviews current Canadian treatment guidelines and briefly describes recent clinical trials that have added knowledge in treating hypertension.
Cardiovascular Reporter
How you lower BP matters: Results of Life
Dr. Gregory Curnew
ECG of the Month
A couple of problems
Dr. Martin Green
Heart Smart Nutrition
NCEP-ATPIII Implications for Diet
Frances Johnson, RD
Recipe of the Month
Halibut with Mango and Red Pepper Salsa
Dr. Shauna Ratner
Dr. Frances Johnson
Patient Information
Reduce Saturated Fats to Lower High Blood Cholesterol
Frances Johnson, RD
Clinical Issues in Hypertension
Diet and Hypertension
Dr. Rhona Hanning
Dr. Norman Campbell
|
|
|
 |
|
|
|
 |
April 2002
A Clinical Approach to Palpitations
The management of patients with palpitations presents a challenge for the primary-care physician. This article provides background information needed in diagnosing and treating a patient suffering from this condition.
By Lorne J. Gula, MD, FRCPC; Andrew D. Krahn, MD, FRCPC; Raymond Yee, MD, FRCPC; Allan C. Skanes, MD, FRCPC; and George J. Klein, MD, FRCPC
Management of Patients Post MI
This article provides readers with the necessary pharmacologic information for treating post-MI patients. Appropriate use of current drugs is discussed, as well as how best to follow your patient.
By Robert C. Welsh, MD, FRCPC
Recipe of the Month Download
|
|
|
 |
March 2002
CHF Management: An Overview
Chronic heart failure (CHF) is often overlooked or misdiagnosed in the early stages and, therefore, undertreated. This article looks at the causes, precipitating factors and pathophysiology of CHF. Diagnostic algorithms and goals of CHF management are also reviewed.
A Drug Review
The authors discuss pharmacologic management of
CHF, looking at the following:
• Diuretics;
• ACE inhibitors;
• ARBs;
• Vasopeptidase inhibitors;
• Nitrates and hydralazine;
• Beta blockers;
• Digoxin; and
• Warfarin
By Amish Raval, MD; and
J. Malcolm O. Arnold, BSc, MD, FRCP, FRCP Edin, FRCPC, FACP, FACC
Recipe of the Month Download
|
|
|
 |
February 2002
When Should I Order An Echo? A Primer for General Practitioners
By Richard Bon, MD; and Ken Gin, MD, FRCPC
The role of echocardiography as a diagnostic, therapeutic and management-guiding tool is becoming increasingly relevant in cardiology and general practice. This article discusses the appropriate application of this form of testing.
The 2001 Canadian Hypertension Recommendations
Prepared by the Canadian Hypertension Recommendations Working Group
This article highlights those recommendations that are new, revised or important to improve blood pressure control in Canada. New recommendations of specific interest include an updated section on management of hypertension in individuals with diabetes.
Recipe of the Month Download
|
|
|
 |
January 2002
Mineralorcorticoid Hypertension:
Common and Treatable
Hypertension is the most common chronic disease treated by the primary-care physician. It is now evident that mineralocorticoid hypertension, which is most commonly caused by primary aldosteronism, is much more prevalent and can be readily diagnosed and treated.
By Thomas R. Wilson, BSc, MEng; Merne Wilson, RN, BScN, MSc; and Thomas W. Wilson, MD, MSc, FRCP
Recipe of the Month Download
|
